Califf’s New Spin On US FDA Staffing: Attrition Rate Is Too Low

 
• By Sarah Karlin-Smith
Front of FDA headquarters
FDA Commissioner Robert Califf discussed a range of regulatory issues at BIO 2023 • Source: Shutterstock/Tada Images

More from US FDA

More from Agency Leadership